ESSA Pharma Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2019 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
ESSA Pharma Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2019 to Q2 2024.
- ESSA Pharma Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$7.23M, a 0.89% increase year-over-year.
- ESSA Pharma Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$27.7M, a 0.89% decline year-over-year.
- ESSA Pharma Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$26.6M, a 24.3% increase from 2022.
- ESSA Pharma Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$35.1M, a 4.63% increase from 2021.
- ESSA Pharma Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$36.8M, a 57% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)